Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep > NAM working with the World Hepatitis Alliance and the European Liver Patients Association www.nam.org.uk www.worldhepatitisalliance.org www.elpa-info.org Jordan Feld and Elana Rosenthal at the AASLD Liver Meeting. Photo by Liz Highleyman.The Liver Meeting: People who inject drugsPeople who inject drugs have a high hepatitis C cure rate despite imperfect adherence. News from The Liver Meeting 2018Sign up for our 2018 Liver Meeting news bulletin. Tracey Simon at The Liver Meeting 2018. Photo by Liz Highleyman.The Liver Meeting: Hepatocellular carcinomaAspirin use associated with lower risk of liver cancer. Alina Allen at The Liver Meeting 2018. Photo by Liz Highleyman.The Liver Meeting: NAFLD and cancerPeople with fatty liver disease are at greater risk for multiple cancers. Kathleen Schwarz at The Liver Meeting 2018. Photo by Liz Highleyman.The Liver Meeting: Treatment outcomesSofosbuvir/ledipasvir cures most young children with hepatitis C. New to hepatitis?Read our introductory information on viral hepatitis > infohep news Treatment for people who use drugs People who inject drugs have a high hepatitis C cure rate despite imperfect adherence Liz Highleyman / 15 November 2018 Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ... Pan-genotypic regimens 8 weeks of Maviret cures 98% of people with hepatitis C and cirrhosis Keith Alcorn / 14 November 2018 An 8-week course of the combination of glecaprevir and pibrentasvir (Maviret) is highly effective in curing hepatitis C in people with compensated cirrhosis, across a wide range of genotypes, Robert S. Brown of ... Hepatocellular carcinoma (HCC) Aspirin use associated with lower risk of liver cancer Liz Highleyman / 13 November 2018 Taking aspirin about twice a week for five years or more may reduce the risk of developing hepatocellular carcinoma (HCC) by about half, according to research presented this week at the AASLD Liver ... Treatment outcomes Sofosbuvir/ledipasvir cures most young children with hepatitis C Liz Highleyman / 13 November 2018 Almost all young children ages 3 to 6 years with chronic hepatitis C achieved sustained virological response after 12 weeks of treatment using sofosbuvir/ledipasvir oral granules, according to findings presented at the ... Sexual transmission Hepatitis C is detectable in rectal and nasal fluid Keith Alcorn / 12 November 2018 High levels of hepatitis C virus (HCV) can be found in the rectal and nasal fluids of people with high hepatitis C viral loads even when blood is not present, Austrian researchers ... View all infohep news Editors' picks from other sources New PHE and NHSE launch national drive to trace hepatitis C patients GOV.UK / 8 hours ago Belarus to increase purchase of hepatitis C drugs twofold BELTA / 20 November 2018 MPP-AbbVie License on Glecaprevir and Pibrentasvir (G/P): Backtracking on Geographic Coverage but with Options for Oppositions, Compulsory Licenses, and Negotiated Territorial Expansion Health GAP / 20 November 2018 Targeted Hepatitis C testing misses substantial number of cases in correctional setting Boston Medical Center press release / 20 November 2018 China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection Gilead press release / 20 November 2018 What's Really Behind the Recent Decline in U.S. Hepatitis C Prevalence? The Body Pro / 15 November 2018 Do Patients with Chronic Liver Disease Face Higher Drug-Induced Liver Injury Risk? MedPage Today / 14 November 2018 Novel Thyroid Beta Receptor Agonist Cut LDL-C in NAFLD Patients MedPage Today Gastroenterology / 14 November 2018 DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link? Monthly Prescribing Reference / 14 November 2018 Universal HCV Screening on the Way? MedPage Today / 12 November 2018 View all news from other sources Latest library resources Safer heroin injecting TypeWeb page Published2013 AuthorJon Derricott A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page CountryRussian Federation, Turkey, Western and Central Europe Published2013 AuthorLiver International Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 TypeWeb page CountryUnited States PublishedApril 2013 AuthorAmerican Association for the Study of Liver Diseases View all resources Looking for country specific news, resources and services?Visit our country information pages > Keep up to date with the latest hepatitis newsSign up for our free monthly email bulletin >